BLACK WEEKSVials −15% · kits −10% · rest −5%with codeFree shipping in Germany from €200
The Peptide Desk The Peptide Desk
Cartalax + TB-500 + BPC-157 Blend, product photo
Healing

Cartalax + TB-500 + BPC-157 Blend

Injectable blend of the cartilage bioregulator Cartalax and the two healing peptides TB-500 and BPC-157. Three tissue regeneration pathways in a single vial.

  • Ships from Germany

Order

Unit price - Free shipping in Germany from €200 during Black Weeks
  • DHL with tracking
  • Discreet packaging

4.6 out of 5 on Trustpilot73 reviews

At a glance

Cartalax + TB-500 + BPC-157 Blend by the numbers

The key figures from our lexicon.

Full lexicon entry
Class
Regeneration blendCartalax + TB-500 + BPC-157
Frequency
Once daily as a course
Sizes
20 mg1 size in the shop

There is no lab analysis for Cartalax + TB-500 + BPC-157 Blend yet. Vote for itHave it tested yourself, we pay halfAll lab analyses

Knowledge

Everything about Cartalax + TB-500 + BPC-157 Blend

Description

This blend combines three research compounds from three different approaches to tissue regeneration in a single injectable vial: Cartalax, the tripeptide Ala-Glu-Asp (AED) from the class of Khavinson bioregulators, TB-500, the synthetic form of the endogenous protein thymosin beta-4, as well as BPC-157, a 15-amino-acid pentadecapeptide derived from a protective protein in gastric juice. Each vial contains 20 mg: 10 mg Cartalax, 5 mg TB-500 and 5 mg BPC-157.

The three components act at different points. In research from the Saint Petersburg Institute of Bioregulation and Gerontology, Cartalax is described as a short peptide that, according to this work, reaches the cell nucleus and epigenetically influences gene expression in cartilage cells (chondrocytes). In cell cultures the AED peptide increased the proliferation of chondrocytes from young and old rats. Review articles associate it with a normalization of age-related inflammation and cell senescence markers in cartilage. TB-500 binds the structural protein actin inside the cell and in preclinical models promotes cell migration, new blood vessel formation and wound healing. In studies BPC-157 acts via the nitric oxide axis and angiogenesis; in tendon fibroblasts it promoted outgrowth, survival under oxidative stress as well as cell migration, probably via the FAK-paxillin pathway.

What needs framing honestly: there are no clinical data on precisely this combination of Cartalax, TB-500 and BPC-157 in one vial. The evidence stems from the individual compounds and is almost entirely preclinical. For Cartalax the work comes almost exclusively from the Khavinson group. Independent international confirmation is missing. On combining BPC-157 and TB-500, a study on the sutured Achilles tendon of the rat found that both individual compounds improved tissue structure while the combination brought no additional benefit. The fixed 2:1:1 ratio cannot be adjusted separately.

You receive this blend as a research compound in 10 vials of 20 mg per vial (10 mg Cartalax plus 5 mg TB-500 plus 5 mg BPC-157) as a lyophilizate for reconstitution with bacteriostatic water, on request also as an in-stock single vial. The format is intended for experimental research approaches.

This information is for research and educational purposes only. Not medical advice.

Risks & Safety

All three components are classified as well tolerated in the available literature. The data on all three are thin and come mostly from animal and cell models; there are no dedicated safety data for the combination.

Observed in studies and user reports:

  • Injection site: mild redness, itching or temporary irritation at the injection site are the most common observations with subcutaneous use.
  • New blood vessel formation: TB-500 and BPC-157 promote angiogenesis in preclinical models. Whether this poses a risk in existing tumors or a history of cancer has not been studied. The literature advises caution in this context.
  • Thin human data: robust human studies on dosing, duration and safety are largely missing for BPC-157 and TB-500. The Cartalax data come almost exclusively from small, Russian-language papers of a single research group.
  • Fixed ratio: the amount of all three components rises and falls together. Anyone wanting to keep one component lower cannot do so with this blend.
  • No long-term data: there are no data on the safety profile of longer or repeated use of the combination.

This classification does not replace medical advice. Risk and responsibility for any actual use lie entirely with the buyer.

Studies

Good to have

What you need with it

Bacteriostatic water is added to your cart automatically. Syringes and swabs with one click.

Insulin Syringes

10 pcs · 5.50 €

Alcohol Swabs

50 pcs · 10 €

How much water?

Units on the syringe for your vial size.

Open calculator →

Related

Related products